News
Acute and longer-term outcomes using ketamine as a clinical treatment at the Yale Psychiatric Hospital
Yale researchers, including first author Samuel Wilkinson, MD, Assistant Professor of Psychiatry, describe in a paper published in Biological Psychiatry their experience providing ketamine as a clinical treatment to participants with severe and treatment-resistant mood disorders.
Source: Biological Psychiatry